Dimensional Fund Advisors
PMVP icon

Dimensional Fund Advisors’s PMV Pharmaceuticals PMVP Stock Holding History

Dimensional Fund Advisors’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,972
Closed -$22.4K – 3303
2025
Q3 		$22.4K Sell
15,972
-238
-1% -$329 ﹤0.01% 3265
2025
Q2 		$17.2K Sell
16,210
-109,794
-87% -$108K ﹤0.01% 3269
2025
Q1 		$137K Hold
126,004
– – ﹤0.01% 3165
2024
Q4 		$190K Hold
126,004
– – ﹤0.01% 3169
2024
Q3 		$188K Hold
126,004
– – ﹤0.01% 3182
2024
Q2 		$204K Sell
126,004
-146,855
-54% -$265K ﹤0.01% 3163
2024
Q1 		$464K Sell
272,859
-284,612
-51% -$532K ﹤0.01% 3056
2023
Q4 		$1.73M Sell
557,471
-20,364
-4% -$53.9K ﹤0.01% 2814
2023
Q3 		$3.55M Buy
577,835
+263,523
+84% +$1.81M ﹤0.01% 2634
2023
Q2 		$1.97M Sell
314,312
-93,000
-23% -$487K ﹤0.01% 2788
2023
Q1 		$1.94M Sell
407,312
-125,237
-24% -$881K ﹤0.01% 2749
2022
Q4 		$4.63K Buy
532,549
+168,193
+46% +$1.79M ﹤0.01% 2483
2022
Q3 		$4.34M Buy
364,356
+227,157
+166% +$3.28M ﹤0.01% 2478
2022
Q2 		$1.95M Buy
+137,199
New +$2M ﹤0.01% 2746

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors's PMVP Position: Q4 2025 in Review

Dimensional Fund Advisors sold out of PMV Pharmaceuticals (PMVP) in Q4 2025, closing a stake of 15,972 shares — an estimated $22.4K sold.

Dimensional Fund Advisors first reported a position in PMVP in Q2 2022 and held it in 14 quarters. The position peaked at $4.34M in Q3 2022. 63 funds tracked by Wall St. Rank hold PMVP as of Q4 2025.

  • Dimensional Fund Advisors reported no remaining PMV Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 15,972 PMV Pharmaceuticals shares in Q4 2025, an estimated $22.4K.
  • Dimensional Fund Advisors first reported a position in PMV Pharmaceuticals in Q2 2022 and held it in 14 quarters.
  • Dimensional Fund Advisors's PMV Pharmaceuticals position peaked at $4.34M in Q3 2022.
  • 63 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2025.

Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.